Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back.

Front Immunol · 2024 · PMC11357913 · PMID 39211043

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Consistent with preclinical findings showing greater antitumor effects of SG in mice bearing tumors with high Trop-2 expression ( 62 , 67 , 68 ), a positive trend was observed in PFS for patients with 2+ or 3+ Trop-2.

also in 6,846 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.